FindTrial
Sign In

haloperidol decanoate

DRUG7 trials

Sponsors

US Department of Veterans Affairs, Central Mental Clinic for Outpatients of Baku City, New York State Psychiatric Institute, University Hospitals Cleveland Medical Center, Northeastern University

Conditions

Advanced CancersMedication NonadherencePatient NoncomplianceSchizo Affective DisorderSchizoaffective DisorderSchizophreniaSubsyndromal Delirium

Phase 2

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer
Active, not recruitingNCT01949662
M.D. Anderson Cancer CenterAdvanced Cancers
Start: 2014-01-01End: 2028-01-01Updated: 2026-07-17

Phase 3

Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY)
CompletedNCT04327843
Case Western Reserve UniversityMedication Nonadherence, Schizo Affective Disorder, Schizophrenia
Start: 2019-11-05End: 2020-07-30Updated: 2021-10-12

Phase 4

Lamictal TM, Haloperidol Decanoate in Schizophrenia
TerminatedNCT00947375
Central Mental Clinic for Outpatients of Baku CitySchizophrenia
Start: 2005-01-31End: 2007-01-31Updated: 2009-07-28
A Comparison of Long-acting Injectable Medications for Schizophrenia
CompletedNCT01136772
New York State Psychiatric InstituteSchizoaffective Disorder, Schizophrenia
Start: 2011-03-31End: 2016-07-31Updated: 2016-10-21
Preventing ICU Subsyndromal Delirium Conversion to Delirium With Haloperidol
CompletedNCT01174290
Northeastern UniversitySubsyndromal Delirium
Start: 2010-09-30End: 2014-03-31Updated: 2017-04-14

Unknown Phase

Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder
CompletedNCT00018642
US Department of Veterans AffairsSchizoaffective Disorder, Schizophrenia
Start: 1997-04-30End: 2002-03-31Updated: 2009-01-21
Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic
CompletedNCT01152697
University Hospitals Cleveland Medical CenterPatient Noncompliance
Start: 2010-06-30End: 2012-08-31Updated: 2014-12-30

Related Papers

An interventional pilot of customized adherence enhancement combined with long-acting injectable antipsychotic medication (CAE-L) for poorly adherent patients with chronic psychotic disorder in Tanzania.
2022-01-272 citations
Heterogeneity of Treatment Effects of Long-Acting Injectable Antipsychotic Medications
The Journal of Clinical Psychiatry2018-11-265 citations
Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care
JAMA2017-09-19196 citations
Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia
JAMA2014-05-20150 citations
Prospective Trial of Customized Adherence Enhancement Plus Long-Acting Injectable Antipsychotic Medication in Homeless or Recently Homeless Individuals With Schizophrenia or Schizoaffective Disorder
The Journal of Clinical Psychiatry2013-12-1539 citations